Philips highlights central role of healthcare in the home at
All-Digital CES 2021
January 11, 2021
- Beyond COVID-19, Philips spotlights care outside of hospital
settings in unique, interactive virtual experience
- Philips executives Deeptha Khanna and Jeroen Tas talk digital
health tech in virtual press conference during CES 2021 Media
Day
- Philips named CES 2021 Innovation Awards honoree for
outstanding technology products across personal and professional
health
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG,
AEX: PHIA), a global leader in health technology, announced its
participation in the first-ever, all-digital CES 2021, beginning
today and running through Jan. 14. Since the initial outbreak of
COVID-19 a year ago, healthcare has experienced a rapid
transformation and acceleration of digital health technologies.
During CES 2021, Philips will highlight a unique hybrid view of
advanced technology solutions fast-tracking healthcare, moving
outside the four walls of the hospital and into the home.
Telehealth, including tele-dentistry, virtual care and remote
monitoring have played significant roles during the pandemic and
will continue to play central roles in health and well-being post
COVID-19 and beyond. At this year’s CES 2021, Philips has created
an interactive virtual healthy neighborhood that visitors can
self-navigate. The immersive experience brings three core
storylines to life, demonstrating how Philips digital health
technology is supporting consumers and patients alike during
COVID-19. From first-time expecting parents, to at-risk people
living with chronic – and often related – conditions like cardiac
disease, diabetes, or sleep apnea, to those who want to improve
their oral health, Philips will spotlight end-to-end solutions to
help safely evaluate and monitor people to better manage healthcare
at home.
Philips CES 2021 virtual press conferencePhilips
executives Deeptha Khanna, Chief Business Leader of Personal
Health, and Jeroen Tas, Chief Innovation & Strategy Officer,
will participate in the Philips CES 2021 virtual press conference
on Monday, January 11 at 10:00 a.m. EST to discuss their vision and
experience in the consumer and professional health tech space.
“Since the onset of the pandemic, we have witnessed a dramatic
shift to online, with the majority of our activities now centered
in the home. We’re working, shopping, educating and connecting with
our caregivers, all from the comfort of our homes. In fact, nearly
half of our Personal Health sales are now made online,” said
Deeptha Khanna, Chief Business Leader, Personal Health, Philips.
“We have also witnessed the reinvention of our homes as a core
element of the healthcare pathway, with telehealth, virtual and
remote care technologies as the key drivers for change during
COVID-19. And these changes are here to stay.”
Philips spotlights remote monitoring, virtual care and
digital health solutions at CES 2021Pregnant mothers are a
vulnerable population and may have several concerns and anxieties
about the impact of COVID-19 infection on pregnancy [1]. Philips
COVID-19 Fetal and Maternal solution within the Avalon product
family, including patch and digital twin of the fetal monitor,
allows clinicians to monitor vital signs of both mom and baby from
home or an isolation room to help reduce unnecessary physical
interactions between clinicians and patients. In the belief that
parents should be able to make decisions based on the best possible
evidence, Philips and GSK have teamed up to equip Philips’
Pregnancy+ and Baby+ apps with comprehensive and reliable
information about vaccine preventable diseases and the vaccines
that are available. The apps, reaching a combined total of nearly 2
million parents worldwide every day, provide articles and videos
about the importance of vaccination, together with a vaccination
hub to help parents access comprehensive and reliable information
to support conversations with their healthcare professionals, such
as which vaccines are relevant and when they need to be
administered. Parents are also invited to participate in on-line
research to help to better understand their views on different
vaccinations.
For people living with health conditions like diabetes or
cardiac disease, Philips will highlight its recently
introduced biosensor-based solutions for remote
monitoring of at-risk chronic disease patients as they transition
from the hospital into the home. Philips will also spotlight
its end-to-end, clinically proven sleep solutions,
designed to help address chronic sleep conditions like sleep apnea
from discovery, to diagnosis, through treatment and adherence –
even from the home. Being showcased for the first time at CES
is the Philips Mask Selector, the first and only clinically
validated, 3D facial scanning solution that helps providers fit 9
out of 10 patients with the right mask from the start [2]. The
proprietary Mask Selector algorithm offers a novel solution in the
shift toward digitization of health care, helping to improve
business efficiencies by reducing costs associated with fitting
time and mask waste.
Philips debuts new Philips Sonicare 9900 Prestige at
CESAs dentist offices closed for a significant period of time
during the height of the pandemic, routine face-to-face dental
check-ups came to a standstill. Taking care of oral health at home
became more important than ever before. Earlier today, Philips
announced the commercial launch of its most recent addition to the
Sonicare line of advanced oral care products with the introduction
of the Sonicare 9900 Prestige. This latest power toothbrush with
Philips SenseIQ technology and in-built artificial intelligence
helps make daily brushing as effective as possible. The Sonicare
9900 Prestige is designed to sense, adapt and care for a
personalized approach to oral care. It is intuitive, adjusting its
settings to a consumer’s personal brushing behavior. For
instance, when applying too much pressure, it automatically adjusts
the brushing intensity.
Philips addresses key areas of health tech focus in CES panel
speaker sessionsDuring CES 2021, Pat Baird, Regulatory
Standards Specialist and Global Head of Software Standards at
Philips will address the trustworthiness of AI in healthcare
through the lens of the end user including physicians, consumers,
professional and family caregivers, public health leaders, medical
societies, and regulators. Joining Philips in the discussion on
Trust and the impact of AI on healthcare are Dr. Jesse Ehrenfeld,
MD, American Medical Association, and Christina Silcox, PhD,
Managing Associate at the Duke-Margolis Center for Health Policy at
Duke University. CES attendees can join the panel session, Jan. 12
at 10:15 a.m. EST.
Building sustainability and battling climate changeRobert
Metzke, Global Head of Sustainability for Philips will also speak
at CES during an in-depth fireside chat titled “Building
Sustainability and Battling Climate Change.” Robert will give his
views on how business leaders are increasingly acknowledging how
critical sustainability is to the future. This session will
premiere on Jan. 13 at 11:30 a.m. EST. Both speaker sessions will
be available on demand for 30 days to all registered CES attendees
following the event.
Philips named CES 2021 Innovation Awards honoreeOn Dec.
15, the Consumer Technology Association (CTA)® announced the CES®
2021 Innovation Awards honorees, including those products
recognized as Best of Innovation. Honorees are recognized for
outstanding products, upcoming trends and how companies are using
technology to change lives for the better. Philips been named a
CES® 2021 Innovation Awards honoree recognized for multiple
technology solutions across personal and professional health
including the Philips Patient Monitoring Kit; the Philips Wearable
Biosensor; the Philips Mask Selector; the Philips Sonicare Prestige
9900; and Philips Teledentistry.
Visit the Philips exhibitor showcase at the all-digital CES 2021
to learn more and follow @PhilipsLiveFrom for live updates
throughout the event. While the Philips virtual healthy
neighborhood experience is built for CES, the platform will be live
throughout the year to continue to demonstrate both Personal Health
and Connected Care technology solutions supporting consumer
health.
[1] Covid-19 related anxiety and concerns expressed by pregnant
and post-partum women – a survey among obstetricians (nih.gov):
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445074/. [2] 2019
Philips sponsored patient preference trial (n=310). Patients
scanned using Mask Selector (n=153) vs. traditional fitting methods
(n=157).
For further information, please contact:
Kathy O’ReillyPhilips Global Press OfficeTel.: +1
978-221-8919E-mail : kathy.oreilly@philips.comTwitter:
@kathyoreilly
Laura SeikrittPhilips Global Press OfficeTel: +31 6
20740318E-mail: laura.seikritt@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2019 sales of EUR 19.5 billion and
employs approximately 81,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- Expecting parents
- Philips Mask Selector 3D CPAP
- Philips Avalon cableless fetal and maternal pod with single-use
disposable patch
- Philips remote patient monitoring with BioIntelliSense
BioSticker
- Philips Sonicare 9900 Prestige power toothbrush with Philips
SenseIQ technology
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Apr 2023 to Apr 2024